These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29778671)

  • 21. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
    Carson JL; Brooks MM; Chaitman BR; Alexander JH; Goodman SG; Bertolet M; Abbott JD; Cooper HA; Rao SV; Triulzi DJ; Fergusson DA; Kostis WJ; Noveck H; Simon T; Steg PG; DeFilippis AP; Goldsweig AM; Lopes RD; White H; Alsweiler C; Morton E; Hébert PC;
    Am Heart J; 2023 Mar; 257():120-129. PubMed ID: 36417955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
    Sidhu MS; Alexander KP; Huang Z; Mathew RO; Newman JD; O'Brien SM; Pellikka PA; Lyubarova R; Bockeria O; Briguori C; Kretov EL; Mazurek T; Orso F; Roik MF; Sajeev C; Shutov EV; Rockhold FW; Borrego D; Balter S; Stone GW; Chaitman BR; Goodman SG; Fleg JL; Reynolds HR; Maron DJ; Hochman JS; Bangalore S;
    JACC Cardiovasc Interv; 2023 Jan; 16(2):209-218. PubMed ID: 36697158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
    Pracoń R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K; Manjunath CN; Smanio PEP; Stone GW; Mancini GBJ; Boden WE; Newman JD; Reynolds HR; Hochman JS; Maron DJ;
    Circ Cardiovasc Interv; 2024 Jun; 17(6):e013435. PubMed ID: 38629312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.
    Chivardi C; Morgan H; Sculpher MJ; Clayton T; Evans R; Dodd M; Petrie M; Rinaldi CA; O'Kane P; Brown L; Perera D; Saramago P;
    Circ Cardiovasc Qual Outcomes; 2024 Jan; 17(1):e010533. PubMed ID: 37929587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
    Bainey KR; Fleg JL; Hochman JS; Kunichoff DF; Anthopolos R; Chernyavskiy AM; Demkow M; Lopez-Quijano JM; Escobedo J; Poh KK; Ramos RB; Lima EG; Schuchlenz H; Ali ZA; Stone GW; Maron DJ; O'Brien SM; Spertus JA; Bangalore S
    Am Heart J; 2022 Jan; 243():187-200. PubMed ID: 34582775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
    Mark DB; Spertus JA; Bigelow R; Anderson S; Daniels MR; Anstrom KJ; Baloch KN; Cohen DJ; Held C; Goodman SG; Bangalore S; Cyr D; Reynolds HR; Alexander KP; Rosenberg Y; Stone GW; Maron DJ; Hochman JS;
    Circulation; 2022 Apr; 145(17):1294-1307. PubMed ID: 35259918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials.
    Galli M; Vescovo GM; Andreotti F; D'Amario D; Leone AM; Benenati S; Vergallo R; Niccoli G; Trani C; Porto I
    Minerva Cardiol Angiol; 2023 Apr; 71(2):221-229. PubMed ID: 33944534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial.
    Park DY; Jamil Y; Moumneh MB; Batchelor B W; Nanna MG; Damluji AA
    Am J Cardiol; 2024 Jul; 223():58-69. PubMed ID: 38797195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
    Chaitman BR; Cyr DD; Alexander KP; Pracoń R; Bainey KR; Mathew A; Acharya A; Kunichoff DF; Fleg JL; Lopes RD; Sidhu MS; Anthopolos R; Rockhold FW; Stone GW; Maron DJ; Hochman JS; Bangalore S
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012103. PubMed ID: 35973009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Strategies for Chronic Coronary Heart Disease with Left Ventricular Systolic Dysfunction or Preserved Ejection Fraction-A Systematic Review and Meta-Analysis.
    Golukhova EZ; Slivneva IV; Kozlova OS; Berdibekov BS; Skopin II; Merzlyakov VY; Baichurin RK; Sigaev IY; Keren MA; Alshibaya MD; Marapov DI; Arzumanyan MA
    Pathophysiology; 2023 Dec; 30(4):640-658. PubMed ID: 38133147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Complete Revascularization in the ISCHEMIA Trial.
    Stone GW; Ali ZA; O'Brien SM; Rhodes G; Genereux P; Bangalore S; Mavromatis K; Horst J; Dressler O; Poh KK; Nath RK; Moorthy N; Witkowski A; Dwivedi SK; Bockeria O; Chen J; Smanio PEP; Picard MH; Chaitman BR; Berman DS; Shaw LJ; Boden WE; White HD; Fremes SE; Rosenberg Y; Reynolds HR; Spertus JA; Hochman JS; Maron DJ;
    J Am Coll Cardiol; 2023 Sep; 82(12):1175-1188. PubMed ID: 37462593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial.
    Udelson JE; Kelsey MD; Nanna MG; Fordyce CB; Yow E; Clare RM; Mark DB; Patel MR; Rogers C; Curzen N; Pontone G; Maurovich-Horvat P; De Bruyne B; Greenwood JP; Marinescu V; Leipsic J; Stone GW; Ben-Yehuda O; Berry C; Hogan SE; Redfors B; Ali ZA; Byrne RA; Kramer CM; Yeh RW; Martinez B; Mullen S; Huey W; Anstrom KJ; Al-Khalidi HR; Chiswell K; Vemulapalli S; Douglas PS;
    JAMA Cardiol; 2023 Oct; 8(10):915-924. PubMed ID: 37610768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
    Gibson CM; Kastelein JJP; Phillips AT; Aylward PE; Yee MK; Tendera M; Nicholls SJ; Pocock S; Goodman SG; Alexander JH; Lincoff AM; Bode C; Duffy D; Heise M; Berman G; Mears SJ; Tricoci P; Deckelbaum LI; Steg PG; Ridker P; Mehran R
    Am Heart J; 2021 Jan; 231():121-127. PubMed ID: 33065120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional imaging after the "ISCHEMIA" trial.
    Duhamel S; Pezel T; Garot J
    Arch Cardiovasc Dis; 2023 Nov; 116(11):529-534. PubMed ID: 37743129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous Coronary Intervention in Stable Coronary Heart Disease -Is Less More?
    Figulla HR; Lauten A; Maier LS; Sechtem U; Silber S; Thiele H
    Dtsch Arztebl Int; 2020 Feb; 117(9):137-144. PubMed ID: 32234189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??
    Boden WE
    Vascul Pharmacol; 2024 Mar; 154():107253. PubMed ID: 38070758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of patients' management based on anatomic/functional phenotype: a study in patients with chronic coronary syndromes.
    Liga R; Neglia D; Cavaleri S; Grasso E; Giorgetti A; Gimelli A
    J Nucl Cardiol; 2023 Apr; 30(2):736-747. PubMed ID: 35941321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Review of Literature Citing the ISCHEMIA Trial.
    King DJ; Eskander C; Ricci J; Gittess D; Patel R; Bourne M; Budweg J; Winchester DE
    Curr Cardiol Rep; 2024 May; 26(5):325-329. PubMed ID: 38492177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the conservative versus invasive management of ischemic heart failure with reduced ejection fraction.
    Matta A; Ohlmann P; Nader V; Levai L; Kang R; Carrié D; Roncalli J
    Curr Probl Cardiol; 2024 Feb; 49(2):102347. PubMed ID: 38103822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.